Except for this unique role in inflammation response, CASC2 also functions as a tumor suppressor and it is downregulated in multiple cancer types including lung cancer 24, gastric cancer 25, colorectal cancer 26, bladder cancer 27, melanoma 28, and glioma 29. Here, CASC2 is linked to neoplasm.